• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老相关心血管疾病中的 RNA 修饰。

RNA modifications in aging-associated cardiovascular diseases.

机构信息

Fangshan Hospital Beijing University of Chinese Medicine, Beijing 102400, China.

Key Laboratory of Chinese Internal Medicine of the Ministry of Education, Dongzhimen Hospital Affiliated with Beijing University of Chinese Medicine, Beijing 100700, China.

出版信息

Aging (Albany NY). 2022 Sep 29;14(19):8110-8136. doi: 10.18632/aging.204311.

DOI:10.18632/aging.204311
PMID:36178367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9596201/
Abstract

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide that bears an enormous healthcare burden and aging is a major contributing factor to CVDs. Functional gene expression network during aging is regulated by mRNAs transcriptionally and by non-coding RNAs epi-transcriptionally. RNA modifications alter the stability and function of both mRNAs and non-coding RNAs and are involved in differentiation, development, and diseases. Here we review major chemical RNA modifications on mRNAs and non-coding RNAs, including N6-adenosine methylation, N1-adenosine methylation, 5-methylcytidine, pseudouridylation, 2' -O-ribose-methylation, and N7-methylguanosine, in the aging process with an emphasis on cardiovascular aging. We also summarize the currently available methods to detect RNA modifications and the bioinformatic tools to study RNA modifications. More importantly, we discussed the specific implication of the RNA modifications on mRNAs and non-coding RNAs in the pathogenesis of aging-associated CVDs, including atherosclerosis, hypertension, coronary heart diseases, congestive heart failure, atrial fibrillation, peripheral artery disease, venous insufficiency, and stroke.

摘要

心血管疾病(CVD)是全球发病率和死亡率的主要原因,给医疗保健带来了巨大负担,而衰老则是 CVD 的主要促成因素。衰老过程中的功能性基因表达网络受到 mRNA 转录调控和非编码 RNA 顺式转录调控。RNA 修饰改变了 mRNA 和非编码 RNA 的稳定性和功能,并参与了分化、发育和疾病。在这里,我们综述了 mRNAs 和非编码 RNA 上的主要化学 RNA 修饰,包括 N6-腺苷甲基化、N1-腺苷甲基化、5-甲基胞嘧啶、假尿嘧啶化、2'-O-核糖甲基化和 N7-甲基鸟苷,重点关注心血管衰老。我们还总结了目前用于检测 RNA 修饰的方法和用于研究 RNA 修饰的生物信息学工具。更重要的是,我们讨论了 RNA 修饰对与衰老相关的 CVD 发病机制中 mRNAs 和非编码 RNA 的具体影响,包括动脉粥样硬化、高血压、冠心病、充血性心力衰竭、心房颤动、外周动脉疾病、静脉功能不全和中风。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/9596201/106bb92c90e8/aging-14-204311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/9596201/c0fb5018eebc/aging-14-204311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/9596201/106bb92c90e8/aging-14-204311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/9596201/c0fb5018eebc/aging-14-204311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b241/9596201/106bb92c90e8/aging-14-204311-g002.jpg

相似文献

1
RNA modifications in aging-associated cardiovascular diseases.衰老相关心血管疾病中的 RNA 修饰。
Aging (Albany NY). 2022 Sep 29;14(19):8110-8136. doi: 10.18632/aging.204311.
2
RNA modifications in cardiovascular diseases, the potential therapeutic targets.心血管疾病中的 RNA 修饰:潜在的治疗靶点。
Life Sci. 2021 Aug 1;278:119565. doi: 10.1016/j.lfs.2021.119565. Epub 2021 May 6.
3
Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases.表观遗传 RNA 甲基化在心血管疾病中的潜在调控作用。
Biomed Pharmacother. 2021 May;137:111376. doi: 10.1016/j.biopha.2021.111376. Epub 2021 Feb 13.
4
Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.变心:心力衰竭中小非编码 RNA 的表观转录组学。
Curr Heart Fail Rep. 2022 Oct;19(5):255-266. doi: 10.1007/s11897-022-00561-2. Epub 2022 Jul 25.
5
Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.长链非编码 RNA/环状非编码 RNA-miRNA-mRNA 轴在心血管疾病中的作用。
Life Sci. 2019 Sep 15;233:116440. doi: 10.1016/j.lfs.2019.04.066. Epub 2019 Apr 30.
6
Long noncoding RNA in cardiac aging and disease.长链非编码 RNA 在心脏衰老和疾病中的作用。
J Mol Cell Biol. 2019 Oct 25;11(10):860-867. doi: 10.1093/jmcb/mjz046.
7
Noncoding RNAs in age-related cardiovascular diseases.非编码 RNA 与年龄相关性心血管疾病。
Ageing Res Rev. 2022 May;77:101610. doi: 10.1016/j.arr.2022.101610. Epub 2022 Mar 23.
8
Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications.循环长非编码 RNA(circulatory-LNC-RNAs)作为心血管疾病的新型生物标志物和治疗靶点:对心血管疾病并发症的影响。
Int J Biol Macromol. 2023 Jan 15;225:1049-1071. doi: 10.1016/j.ijbiomac.2022.11.167. Epub 2022 Nov 19.
9
Long Noncoding Competing Endogenous RNA Networks in Age-Associated Cardiovascular Diseases.长非编码竞争性内源性 RNA 网络与年龄相关心血管疾病。
Int J Mol Sci. 2019 Jun 24;20(12):3079. doi: 10.3390/ijms20123079.
10
N6-Adenosine Methylation (mA) RNA Modification: an Emerging Role in Cardiovascular Diseases.N6-腺苷甲基化 (mA) RNA 修饰:在心血管疾病中的新兴作用。
J Cardiovasc Transl Res. 2021 Oct;14(5):857-872. doi: 10.1007/s12265-021-10108-w. Epub 2021 Feb 25.

引用本文的文献

1
N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential.癌症中的N7-甲基鸟苷修饰:从机制到治疗潜力
J Hematol Oncol. 2025 Jan 29;18(1):12. doi: 10.1186/s13045-025-01665-7.
2
Whole Blood Metabolomic Profiling of Mice with Tacrolimus-Induced Chronic Nephrotoxicity: NAD Depletion with Salvage Pathway Impairment.他克莫司诱导的慢性肾毒性小鼠的全血代谢组学分析:伴有补救途径损伤的NAD耗竭
Antioxidants (Basel). 2025 Jan 7;14(1):62. doi: 10.3390/antiox14010062.
3
Molecular insights into regulatory RNAs in the cellular machinery.

本文引用的文献

1
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
2
Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake.衰老、与年龄相关的心血管风险以及天然成分摄入的有益作用。
Int J Mol Sci. 2021 Dec 24;23(1):183. doi: 10.3390/ijms23010183.
3
N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis.
分子层面解析细胞机制中的调控 RNA。
Exp Mol Med. 2024 Jun;56(6):1235-1249. doi: 10.1038/s12276-024-01239-6. Epub 2024 Jun 14.
4
Unlocking the dark matter: noncoding RNAs and RNA modifications in cardiac aging.揭示暗物质:心脏衰老中的非编码 RNA 和 RNA 修饰。
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H832-H844. doi: 10.1152/ajpheart.00532.2023. Epub 2024 Feb 2.
5
Non-Coding RNA-Mediated Gene Regulation in Cardiovascular Disorders: Current Insights and Future Directions.非编码 RNA 在心血管疾病中的基因调控:当前的认识和未来方向。
J Cardiovasc Transl Res. 2024 Aug;17(4):739-767. doi: 10.1007/s12265-023-10469-4. Epub 2023 Dec 13.
N7-甲基鸟苷修饰在低氧性肺动脉高压大鼠模型中的长链非编码 RNA :全面分析。
BMC Genomics. 2022 Jan 7;23(1):33. doi: 10.1186/s12864-021-08188-8.
4
2'O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases.核糖体 RNA 的 2'O-核糖甲基化:活生物体、生物过程和疾病中的天然多样性。
Cells. 2021 Jul 31;10(8):1948. doi: 10.3390/cells10081948.
5
Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.腺苷到肌苷的 Alu RNA 编辑控制着动脉粥样硬化性心血管疾病中促炎长非编码 RNA NEAT1 的稳定性。
J Mol Cell Cardiol. 2021 Nov;160:111-120. doi: 10.1016/j.yjmcc.2021.07.005. Epub 2021 Jul 21.
6
m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation.m7G甲基转移酶METTL1通过促进VEGFA mRNA翻译来促进缺血后血管生成。
Front Cell Dev Biol. 2021 May 31;9:642080. doi: 10.3389/fcell.2021.642080. eCollection 2021.
7
RNA modifications in cardiovascular diseases, the potential therapeutic targets.心血管疾病中的 RNA 修饰:潜在的治疗靶点。
Life Sci. 2021 Aug 1;278:119565. doi: 10.1016/j.lfs.2021.119565. Epub 2021 May 6.
8
Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭中m6A RNA甲基化的改变
Front Cardiovasc Med. 2021 Mar 5;8:647806. doi: 10.3389/fcvm.2021.647806. eCollection 2021.
9
Modeling multi-species RNA modification through multi-task curriculum learning.通过多任务课程学习对多物种 RNA 修饰进行建模。
Nucleic Acids Res. 2021 Apr 19;49(7):3719-3734. doi: 10.1093/nar/gkab124.
10
METTL3-dependent N-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium.METTL3 依赖性 N6-甲基腺苷 RNA 修饰调控血管内皮致动脉粥样硬化性炎症反应级联。
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7). doi: 10.1073/pnas.2025070118.